The 2021 Hybrid Summit covers both small molecules and biologicsnew technologiesconcepts and case studies in areas such as:
  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars


Know moreBook a meeting